ViiV Healthcare Company et al v. Aurobindo Pharma Ltd. et al
| ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No.3) Limited |
| Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. |
| 1:2026cv01175 |
| September 18, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 18, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 Summons Issued as to Aurobindo Pharma Ltd. on 9/18/2026; Aurobindo Pharma USA, Inc. on 9/18/2026. (Attachments: #1 Summons Issued)(mpb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Shionogi & Co., Ltd. (mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent(s) ViiV Healthcare Company and Corporate Parent Viiv Healthcare UK Limited and Other Affiliate(s) Pfizer Inc., Shionogi & Co., Ltd., GSK plc, GlaxoSmithKline Mercury Limited, PHIVCO Luxembourg Sarl, Shionogi B.V., and PHIVCO Corp. for ViiV Healthcare UK (No.3) Limited. Corporate Parent(s) ViiV Healthcare Limited and Other Affiliate(s) Pfizer Inc., GSK plc, GlaxoSmithKline Mercury Limited, PHIVCO Luxembourg Sarl, Shionogi B.V., and PHIVCO Corp., PHIVCO Luxembourg Sarl, PHIVCO Corp., Pfizer, Inc., and Shionogi & Co., Ltd for ViiV Healthcare Company - filed by ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/6/2026. Date of Expiration of Patent: 12/8/2029.Thirty Month Stay Deadline: No earlier than 2/6/2029. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-5068702) - filed by ViiV Healthcare UK (No.3) Limited, Shionogi & Co., Ltd., ViiV Healthcare Company. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
